GRIMES & COMPANY, INC. – Marinus Pharmaceuticals, Inc. Transaction History
GRIMES & COMPANY, INC. portfolio value:
$230,000
portfolio value
GRIMES & COMPANY, INC. quarter portfolio value change:
+37.40%
quarter
Marinus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +2.21% | 750 shares | 66K | $6.65 | 34.62K |
| Q2 2022 | share | Increase | +3.40% | 1.11K shares | -142K | $4.84 | 33.87K |
| Q1 2022 | share | Increase | +27.59% | 7.08K shares | 1K | $9.35 | 32.76K |
| Q4 2021 | share | Decrease | -11.84% | -3.44K shares | -26K | $11.98 | 25.68K |
| Q3 2021 | share | Increase | +10.20% | 2.69K shares | -143K | $11.38 | 29.12K |
| Q2 2021 | share | Increase | +10.94% | 2.60K shares | 105K | $17.94 | 26.43K |
| Q1 2021 | share | Increase | +94.49% | 11.57K shares | 220K | $15.48 | 23.82K |
| Q4 2020 | share | Increase | +8.89% | 1K shares | 4K | $12.2 | 12.25K |
| Q3 2020 | share | Increase | 0.00% | 11.25K shares | 145K | $12.85 | 11.25K |